glp 1 super responders Some people lose far more weight than others on GLP-1s like Wegovy. Here's why GLP-1 Weight Loss Medications Explained:

Lam CSP, Ramasundarahettige C, Branch KRH et al (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial

Research in autoimmunity, as well as population studies such as the NHANES survey, support achieving sufficiency and balance while avoiding excesses among nutrients for thyroid function

Other peptides signal more effectively

CJC-1295 with DAC is a long-lasting version of a growth hormonereleasing peptide

The FDA also notes that no safety-related information regarding DSIP has been identified, so its unknown whether it could be harmful to humans.26 Given these conclusions, we shouldnt be surprised that DSIP is not an FDA-approved peptide therapy

Clinical studies typically use 100200 mg daily, which is considered unlikely to cause harm for most adults